TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
An October 20, 2026, endocrinology roundup highlighted research finding that about one-quarter of active-duty Army men had a single morning testosterone reading below 300 ng/dL. It also summarized U.S. menopause symptom and prescription-use figures, and an analysis of Reddit posts describing adverse events among people who said they used unapproved retatrutide. The findings have important limits: they do not establish a diagnosis in individual soldiers or determine the drug’s safety or side-effect rates.
A MedPage Today endocrinology roundup published October 20, 2026, highlighted three findings: roughly one-quarter of active-duty U.S. Army men had a single morning testosterone concentration below 300 ng/dL; nearly half of U.S. women ages 40 to 60 reported menopausal symptoms in 2025; and an analysis of Reddit posts identified side-effect terms among users who said they took unapproved retatrutide. The findings describe different populations and kinds of evidence, and none alone establishes a clinical diagnosis or a drug’s overall safety.
The Army finding, attributed in the roundup to a study in JAMA, was based on one morning testosterone measurement. The reported level, below 300 ng/dL, is a commonly used cutoff for low testosterone. The roundup does not provide the study’s sample size, how soldiers were selected, or whether anyone had symptoms or a repeat test. A single below-cutoff result is not, by itself, enough information to determine how many soldiers have a clinical condition.
A separate CDC report found that nearly half of American women ages 40 to 60 reported menopausal symptoms in 2025. Among that group, 15.6% were taking prescription medication for those symptoms. The figures describe reported symptoms and medication use; they do not specify which treatments women used or whether those taking medication experienced symptom relief.
The roundup also described an analysis published in JAMA Network Open of Reddit users reporting use of retatrutide, an unapproved weight-loss drug. Frequently cited adverse-event terms included increased appetite, fatigue, increased energy, insomnia, increased heart rate and muscle-related symptoms. This is an analysis of online posts, not a controlled clinical trial: it cannot establish how common the effects are among all users or prove that the drug caused them.
What the Findings Can Tell Patients
Together, the reports draw attention to endocrine health across distinct groups: military men, women reporting menopause symptoms and people discussing an investigational weight-loss drug online. The Army result could prompt questions about how testosterone is measured and interpreted in a large, physically demanding workforce. But the reported proportion should not be treated as the share of soldiers who need treatment without further clinical information.
The menopause figures offer a population-level view of reported symptoms and prescription use, while the Reddit analysis shows what people are discussing after taking a drug that is not approved. These sources serve different purposes. Self-reported online posts can flag experiences for further study, but they do not provide a reliable rate of side effects. Readers should not use the posts as a substitute for medical advice, and the roundup does not establish that retatrutide is safe or effective.
men's testosterone booster supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Three Findings, Different Evidence
The October 20 roundup gathered research and industry news from several sources rather than reporting a single study. Alongside the testosterone, menopause and retatrutide items, it summarized a National Health Interview Survey finding that one in six adults with type 1 diabetes reported moderate to severe depression or anxiety symptoms. It also cited a phase III data meta-analysis linking greater weight reduction from GLP-1 receptor agonists and emerging multi-hormone receptor modulators with larger drops in blood pressure.
Other items included a company-reported, post-hoc analysis of a phase III trial of semaglutide plus cagrilintide. Novo Nordisk said the combination was associated with average weight loss of 25% among women, with similar results across pre-, peri- and postmenopausal stages. The roundup also reported that Walmart planned to cover more than 250 prescription drugs, including some insulins and GLP-1 medicines for diabetes, at no cost for employees in 2027. These separate developments provide context on the breadth of the roundup but do not change the limits of the three headline findings.
“Roughly a quarter of active-duty U.S. Army men had a single morning testosterone concentration under 300 ng/dL.”
— MedPage Today, summarizing the Army testosterone study
As an affiliate, we earn on qualifying purchases.
Limits of the Available Data
The roundup does not provide enough detail to assess the Army study’s design, sample size, participant characteristics or the number of men with symptoms and repeat low readings. The single-test result cannot show how many soldiers meet clinical criteria for low testosterone or whether the reading affected their health or military service.
For the menopause statistics, the summary does not identify the medications counted or give details about symptom severity and treatment outcomes. For retatrutide, Reddit posts are voluntary and self-reported; the analysis cannot confirm every user’s exposure, verify symptoms or calculate how often an adverse event occurs. Whether the reported effects were caused by retatrutide remains undetermined from this kind of evidence, and the roundup gives no trial data that would resolve that question.
weight loss supplements with retatrutide
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Further Evidence Could Clarify
More complete study reports would be needed to clarify the Army finding, including details on repeat testing, symptoms and the population studied. Further CDC data could show whether menopause symptom reporting and prescription use change over time, while treatment-specific information would help explain what the 2025 medication figure represents.
Retatrutide safety questions require evidence beyond social media posts, such as systematically collected data from clinical studies and safety monitoring. The roundup does not announce a result or date for a follow-up study on these findings. Until stronger evidence is available, the Reddit analysis should be read as a record of reported experiences, not a measure of risk. People considering medicines for testosterone, menopause symptoms or weight management should discuss options and risks with a qualified clinician.
natural remedies for low testosterone
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Does one low testosterone reading mean an Army man has low testosterone?
No. The reported finding concerned a single morning measurement below 300 ng/dL, a commonly used cutoff. The roundup does not say how many men had symptoms or repeat low readings, so it does not establish how many had a clinical diagnosis.
How many women reported menopause symptoms in the CDC figures?
The CDC report cited in the roundup found that nearly half of U.S. women ages 40 to 60 reported menopausal symptoms in 2025. It said 15.6% of that group were taking prescription medication for symptoms.
Do the Reddit posts show how often retatrutide causes side effects?
No. The analysis identified terms in posts from people who said they used retatrutide, but online reports cannot establish side-effect rates or causation. Retatrutide is described in the roundup as unapproved.
What side effects were mentioned in the Reddit analysis?
Frequently cited terms included increased appetite, fatigue, increased energy, insomnia, increased heart rate and muscle-related symptoms. The analysis does not establish that retatrutide caused these experiences.
What is not yet known from this roundup?
The summary does not provide full study methods for the Army or Reddit findings, confirm clinical diagnoses, or show treatment outcomes for the menopause figures. It also does not provide evidence that determines how common or drug-related the reported retatrutide effects are.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
